市场规模和增长是容易的一半。制胜权——体现在净收入留存率和CAC回收期上——才是决定结果的那一半。 B2B SaaS公司面对的这个问题版本，并非通用版。增长已从42%降至32%，而60%的收入集中在经济效益最差的细分市场——因此忽略净收入留存率的答案必然错误。分析必须从各细分市场的CAC回收期和ACV入手，而非从收入开始。
市场规模和增长是容易的一半。制胜权——体现在净收入留存率和CAC回收期上——才是决定结果的那一半。 B2B SaaS公司面对的这个问题版本，并非通用版。增长已从42%降至32%，而60%的收入集中在经济效益最差的细分市场——因此忽略净收入留存率的答案必然错误。分析必须从各细分市场的CAC回收期和ACV入手，而非从收入开始。
新细分市场的评估通常看ARR潜力和扩张路径，这两者都能建模，却都无法预测成功。真正起决定作用的是已有的可迁移部分——支持落地并扩展的现有客户基础、可复制的销售动作，或能降低CAC的数据——以及必须从零构建的部分。
一个细分市场ACV可能很高，但CAC回收期仍不理想时，依然是错误选择。反之亦然：ACV适中但现有客户关系能改善净收入留存率的市场，通常优于每个新客户都需从与竞争对手相同成本位置起步的市场。
另一项纪律是在进入前设定明确的终止标准，因为新细分市场的投入极易多年消耗工程和销售产能，理由只是净收入留存率接近目标。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 判断主要依据预测ARR和细分市场增长率
✓ 没有人写下触发退出的净收入留存率或CAC回收期阈值
✓ 核心ARR增长已放缓，却要求新细分市场恢复整体增长
通常会让情况更糟的做法。 因核心ARR增长停滞而进入，把创始人注意力从仍占大部分收入的细分市场拉开。
It is for you if you run or finance a B2B SaaS company and the case rests mainly on market size and growth rate. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家B2B SaaS公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Market Entry & Expansion Strategy, one of 29 engagements the platform runs. For B2B SaaS公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
列出你已拥有且新市场认可的要素，以及该市场中可信在位者拥有而你没有的要素。如果后者更长且包含结构性内容——分销、监管、数据深度——则进入是一次构建，而非扩展。
在开始前设定数字，并将超过该数字视为终止标准，而非追加投入的理由。大多数失败的进入从未被终止，只是缓慢耗尽。
whichever reuses more of what you already have. Geography usually reuses the product and rebuilds distribution; a new segment usually reuses distribution and rebuilds the product. Whichever rebuild is smaller is the safer bet.
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית